Quadruple Therapy Costs Prohibitive for Many HFrEF Patients

Regardless of their Medicare plan, every patient hits catastrophic coverage by year’s end at current pricing, new numbers show.

Related Keywords

Boston ,Massachusetts ,United States ,America ,American ,Annac Okelly ,Mitchell Psotka ,Kamil Faridi ,Boehringer Ingelheim Eli Lilly ,Kamilf Faridi ,Jasonh Wasfy ,Falls Church ,Heart Failure Society Of America ,American Heart Association ,Md Yale School Of Medicine ,Vascular Institute ,American College Of Cardiology ,Astrazeneca ,European Society Of Cardiology ,Journal Of The American College Cardiology ,American College ,Heart Failure Society ,European Society ,Yale School ,New Haven ,Medicare Advantage ,Inova Heart ,Catastrophic Coverage ,Eli Lilly ,Based Pricing ,Massachusetts General Hospital ,Federal Trade Commission ,